<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01107769</url>
  </required_header>
  <id_info>
    <org_study_id>VISVAL01</org_study_id>
    <nct_id>NCT01107769</nct_id>
  </id_info>
  <brief_title>VISIONAIRE™ Value Study</brief_title>
  <official_title>A Single-center, Randomized, Value Study of VISIONAIRE™ Patient Matched Technology vs. Standard Surgical Instrumentation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smith &amp; Nephew, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smith &amp; Nephew, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single center randomized observational study that evaluates the cost benefit ratio&#xD;
      between the use of two types of instrumentation in TKA: standard instrumentation vs.&#xD;
      VISIONAIRE™ Patient Matched Technology. This study does not involve treatment or&#xD;
      investigational products, as all components are FDA approved and are commercially available.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the current observational study is to assess value of surgical&#xD;
      instrumentation following analysis of health economic data. It is hypothesized that patient&#xD;
      matched cutting block technology VISIONAIRE™ may reduce TKA operative time, blood loss,&#xD;
      surgical error and adverse event risk as well as providing improved mechanical alignment. In&#xD;
      order to test this hypothesis, subjects will be randomized to either VISIONAIRE™ or standard&#xD;
      TKA instrumentation groups. One site will enroll a total of 38 patients; 19 patients per&#xD;
      group. All patients meeting the inclusion/exclusion criteria specified in this protocol will&#xD;
      be asked to participate in the study. If the patient consents to participate, they will be&#xD;
      enrolled in the study and randomized to one of the two study arms. Patients requiring TKA&#xD;
      will be implanted with Legion, Genesis II or Journey BCS (Smith &amp; Nephew) total knee implant&#xD;
      systems. Standard instrumentation will be used to assist the surgeon in placing the implant&#xD;
      in the control group. In the VISIONAIRE™ group, standard instrumentation will not be used in&#xD;
      the surgery. Patients randomized to the VISIONAIRE™ arm will have an MRI preoperatively that&#xD;
      will be used to create the customized cutting blocks. All patients will have an x-ray at each&#xD;
      postoperative interval.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Health Economic Criteria</measure>
    <time_frame>Up to 6 weeks</time_frame>
    <description>This study will evaluate the cost benefit ratio between the use of two types of instrumentation in TKA: standard instrumentation vs. VISIONAIRE™. The following will be collected &amp; reported from the OR and discharge report:&#xD;
instrument tray set-up time&#xD;
operative time&#xD;
blood loss&#xD;
instrumentation requirements&#xD;
discharge disposition&#xD;
ambulatory support on discharge&#xD;
adverse event</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Adverse Events as a measure of Safety and Tolerability</measure>
    <time_frame>Perioperative &amp; Postoperative (up to 6 weeks)</time_frame>
    <description>Radiographic analysis will be conducted to assess preoperative and postoperative mechanical alignment between groups. All perioperative and postoperative surgical or instrument-related adverse events will be recorded during this study.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">38</enrollment>
  <condition>Osteoarthritis of the Knee</condition>
  <arm_group>
    <arm_group_label>VISIONAIRE™</arm_group_label>
    <description>Total knee arthroplasty with VISIONAIRE™ patient-matched cutting blocks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Instrumentation</arm_group_label>
    <description>Total knee arthroplasty with standard instrumentation</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The patient population considered for this study includes patients with osteoarthritis&#xD;
        (degenerative joint disease)of the knee requiring unilateral TKA.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients must meet all of the inclusion criteria.&#xD;
&#xD;
          1. Patient is diagnosed with degenerative joint disease of the knee requiring a&#xD;
             unilateral TKA.&#xD;
&#xD;
          2. Patient is of legal age to consent, and is skeletally mature.&#xD;
&#xD;
          3. Patient is willing to sign and date an IRB/IEC approved consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients must not meet any of the exclusion criteria.&#xD;
&#xD;
          1. Patient has poor bone stock making a TKA unjustifiable.&#xD;
&#xD;
          2. Patient has active, local infection or previous intra-articular infections.&#xD;
&#xD;
          3. Patient has neuropathic (Charcot) joint.&#xD;
&#xD;
          4. Patient is pregnant or may become pregnant during the course of the study.&#xD;
&#xD;
          5. Patient is severely overweight (BMI &gt;40).&#xD;
&#xD;
          6. Patient is a prisoner.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Noble, Jr, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for Orthopaedics Lake Charles, LA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>John Noble, Jr.</name>
      <address>
        <city>Lake Charles</city>
        <state>Louisiana</state>
        <zip>70605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/21908169</url>
    <description>The Value of Patient-Matched Instrumentation in Total Knee Arthroplasty.</description>
  </link>
  <results_reference>
    <citation>J Arthroplasty. 2011 Sep 9. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/21908169</citation>
  </results_reference>
  <results_reference>
    <citation>Noble JW Jr, Moore CA, Liu N. The value of patient-matched instrumentation in total knee arthroplasty. J Arthroplasty. 2012 Jan;27(1):153-5. doi: 10.1016/j.arth.2011.07.006. Epub 2011 Sep 9.</citation>
    <PMID>21908169</PMID>
  </results_reference>
  <verification_date>November 2011</verification_date>
  <study_first_submitted>April 9, 2010</study_first_submitted>
  <study_first_submitted_qc>April 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2010</study_first_posted>
  <last_update_submitted>November 18, 2011</last_update_submitted>
  <last_update_submitted_qc>November 18, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

